GRETA HECKMANN: Open Payments
NPI 1427658368 · DALTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$11,870 in 130 payments from 18 companies in 2025. Trend: 2023 $2,556 · 2024 $10,712 · 2025 $11,870
Speaker / faculty: $7,606Food & beverage: $2,910Travel & lodging: $1,023Consulting: $330
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 27 | $9,520 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $388 |
| ABBVIE INC. | 19 | $385 |
| Axsome Therapeutics, Inc. | 12 | $358 |
| Otsuka America Pharmaceutical, Inc. | 11 | $251 |
| Alkermes, Inc. | 8 | $177 |
| Vanda Pharmaceuticals Inc. | 8 | $145 |
| Lundbeck LLC | 7 | $140 |
| Neurocrine BioSciences, Inc. | 7 | $135 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $84 |
Products named: AUSTEDO XR, CAPLYTA, VRAYLAR, Auvelity, REXULTI, ARISTADA, FANAPT, INGREZZA.
Industry payments across GA — which companies pay providers there.
